MTOR and polycystic kidney disease: Although treatment with mTOR inhibitors has shown positive results in preventing massive renal enlargement in a variety of polycystic kidney disease (PKD) animal models, clinical trials have not been able to show the same beneficial effect of mTOR inhibitors treatment in ADPKD patients4–8.